Publications – Center for Communicable Disease Dynamics

Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts.

Author(s): Tran TN, Wikle N, Albert J, Inam H, Strong E, Břinda K, Leighow SM, Yang F, Hossain S, Pritchard JR, Chan P, Hanage WP, Hanks EM, Boni MFJournal: medRxivPMID: 33469599 January 2021

As three SARS-CoV-2 vaccines come to market in Europe and North America in the winter of 2020-2021, distribution networks will…

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.

Author(s): Bryant JE, Azman AS, Ferrari MJ, Arnold BF, Boni MF, Boum Y, Hayford K, Luquero FJ, Mina MJ, Rodríguez-Barraquer I, Wu JT, Wade D, Vernet G, Leung DTJournal: Sci ImmunolPMID: 32430309 May 2020

Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of…

Nonannual seasonality of influenza-like illness in a tropical urban setting.

Author(s): Lam HM, Wesolowski A, Hung NT, Nguyen TD, Nhat NTD, Todd S, Vinh DN, Vy NHT, Thao TTN, Thanh NTL, Tin PT, Minh NNQ, Bryant JE, Buckee CO, Ngoc TV, Chau NVV, Thwaites GE, Farrar J, Tam DTH, Vinh H, Boni MFJournal: Influenza Other Respir VirusesPMID: 30044029 November 2018

In temperate and subtropical climates, respiratory diseases exhibit seasonal peaks in winter. In the tropics, with no winter, peak timings…

Impact of human mobility on the emergence of dengue epidemics in Pakistan.

Author(s): Wesolowski A, Qureshi T, Boni MF, Sundsøy PR, Johansson MA, Rasheed SB, Engø-Monsen K, Buckee COJournal: Proc Natl Acad Sci U S APMID: 26351662 September 2015

The recent emergence of dengue viruses into new susceptible human populations throughout Asia and the Middle East, driven in part…

Measuring the association between artemisinin-based case management and malaria incidence in southern Vietnam, 1991-2010.

Author(s): Peak CM, Thuan PD, Britton A, Nguyen TD, Wolbers M, Thanh NV, Buckee CO, Boni MFJournal: Am J Trop Med HygPMID: 25667053 April 2015

In addition to being effective, fast-acting, and well tolerated, artemisinin-based combination therapies (ACTs) are able to kill certain transmission stages…